TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EPIKAST

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EPIKAST

ST13

US500000099298653

Classe

35, 41, 42, 44

Pedido

99298653

Registro

8331082

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

24

Atualização mais recente

07/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

35, 41, 42, 44

Data de depósito

23/07/2025

Data de registro

07/07/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

07/07/2026

Última transação

07/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Primeiro uso

2024-05-00

Primeiro uso no comércio

2024-05-00

Código do desenho

4

Tipo de titular

99

Localização do titular

New York, NY, US

Examinador

CASTRO, GIANCARLO

Unidade examinadora

M10

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Epikast, Inc.

Representantes

Betsy Wang Lee Orrick, Herrington & Sutcliffe LLP

Classificação técnica

Classes Nice

Classe 35Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Business organization consulting in the pharmaceutical, biotechnology and life sciences fields; advertising and marketing in the pharmaceutical, biotechnology and life sciences fields; analyzing and compiling business data in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; promoting the exchange of health information within the medical community to achieve advances in the field of healthcare and promote patient adherence

Classe 41

Educational services, namely, providing non-downloadable webinars and live workshops in the field of pharmaceutical sales; providing on-line non-downloadable videos in the field of pharmaceutical sales; providing on-line non-downloadable publications in the nature of articles and white papers in the field of pharmaceutical sales; providing podcasts in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields via email; educational services, namely, providing non-downloadable webinars and live workshops in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing on-line non-downloadable publications in the nature of articles and white papers in the field of clinical trials; providing on-line non-downloadable videos in the field of clinical trials; providing podcasts in the field of clinical trials

Classe 42

Medical, scientific and data analysis research services, namely, analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development and clinical research services, consulting services in the area of pharmaceutical clinical testing, namely, artificial intelligence (AI) powered data management of clinical trials, biostatistical analysis, preclinical research and development evaluation; providing scientific research information to healthcare professionals, patients, and medical, pharmaceutical and biotechnology companies, using artificial intelligence (AI) models that provide insights from transcripts and artificial intelligence (AI) models that summarize the latest medical knowledge in a particular field; creating blogs about medical and pharmaceutical information related to chronic illnesses and disease; hosting an online community website for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the sharing of medical and pharmaceutical information

Classe 44

Providing medical information to physicians and health care professionals; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications

Publicações

Histórico de despachos e eventos da marca no USPTO.

24 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/07/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/07/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

19/05/2026

PUBO

PUBLISHED FOR OPPOSITION

19/05/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/05/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/04/2026

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

21/04/2026

PBSR

WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST

24/02/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/02/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

03/02/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/02/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

03/02/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/02/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

16/01/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/01/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/01/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/01/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

15/12/2025

GNRT

NON-FINAL ACTION E-MAILED

15/12/2025

CNRT

NON-FINAL ACTION WRITTEN

15/12/2025

DOCK

ASSIGNED TO EXAMINER

09/12/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/12/2025

MAFR

APPLICATION FILING RECEIPT MAILED

23/07/2025

NWAP

NEW APPLICATION ENTERED

23/07/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EPIKAST ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.